Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Goebell

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Der Urologe. Ausg. A|May 20, 2006
[Value of systemic chemotherapy in bladder cancer]P J Goebell, F vom Dorp, H Rübben
Der Urologe. Ausg. A|March 4, 2006
[The causes of urinary bladder cancer and possibilities of prevention]K Golka, A W Rettenmeier, P J Goebell
Der Urologe. Ausg. A|April 9, 2010
[Value of biomarkers in urology]P J Goebell, B Keck, S Wach, et al.
Der Urologe. Ausg. A|July 3, 2007
[The "proteomics forum". Interdisciplinary proteome research by the Essen University Clinic]P J Goebell, H Rübben, G Müller, et al.
Der Urologe. Ausg. A|July 11, 2007
[Transurethral resection of bladder tumors and prostate enlargement in physiological saline solution (TURIS). A prospective study]A Rose, S Suttor, P J Goebell, et al.
World Journal of Urology|March 5, 2019
Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative reviewF Kunath, P J Goebell, B Wullich, et al.
European Urology|December 9, 2000
p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?B J Schmitz-Dräger, P J Goebell, T Ebert, et al.
Der Urologe. Ausg. A|June 21, 2008
[Multimodal therapy for bladder sparing with high grade bladder tumors]P J Goebell, W Legal, C Weiss, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|February 5, 1999
[Pelvic exenteration from the surgical viewpoint]P E Goretzki, P J Goebell, T Vogel, et al.
The Journal of Urology|September 20, 2008
Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 casesH M Fritsche, M Burger, S Denzinger, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Der Urologe. Ausg. A|May 20, 2006
[Value of systemic chemotherapy in bladder cancer]P J Goebell, F vom Dorp, H Rübben
Der Urologe. Ausg. A|March 4, 2006
[The causes of urinary bladder cancer and possibilities of prevention]K Golka, A W Rettenmeier, P J Goebell
Der Urologe. Ausg. A|April 9, 2010
[Value of biomarkers in urology]P J Goebell, B Keck, S Wach, et al.
Der Urologe. Ausg. A|July 3, 2007
[The "proteomics forum". Interdisciplinary proteome research by the Essen University Clinic]P J Goebell, H Rübben, G Müller, et al.
Der Urologe. Ausg. A|July 11, 2007
[Transurethral resection of bladder tumors and prostate enlargement in physiological saline solution (TURIS). A prospective study]A Rose, S Suttor, P J Goebell, et al.
World Journal of Urology|March 5, 2019
Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative reviewF Kunath, P J Goebell, B Wullich, et al.
European Urology|December 9, 2000
p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?B J Schmitz-Dräger, P J Goebell, T Ebert, et al.
Der Urologe. Ausg. A|June 21, 2008
[Multimodal therapy for bladder sparing with high grade bladder tumors]P J Goebell, W Legal, C Weiss, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|February 5, 1999
[Pelvic exenteration from the surgical viewpoint]P E Goretzki, P J Goebell, T Vogel, et al.
The Journal of Urology|September 20, 2008
Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 casesH M Fritsche, M Burger, S Denzinger, et al.
Pageof 4